Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas - Ramanathan, R K; Goldstein, D; Korn, R L (Ann Oncol, 2016)
et al.